World failed to achieve 2020 mental health target: WHO

New Delhi: The world missed most of the 2020 mental health targets, and has failed to provide people with the mental health services they need, at a time when the Covid-19 pandemic is highlighting a growing need for mental health support, according to a World Health Organisation (WHO) report released on Friday. The Mental Health Atlas report, released ahead of the World Mental Health Day on October 10, includes data from 171 countries. It showed that despite increase in attention given to mental health in recent years, it is yet to result in a scale-up of quality mental services that is aligned with needs.

In 2020, just 51 per cent of WHO’s 194 member states reported that their mental health policy or plan was in line with international and regional human rights instruments, way short of the 80 per cent target. Only 52 per cent of countries met the target relating to mental health promotion and prevention programmes, yet well below the 80 per cent target.

Reduction in the rate of suicide by 10 per cent, was the only target met, but even then, only 35 countries had a stand-alone prevention strategy, policy or plan, said the report released every three years.

“It is extremely concerning that, despite the evident and increasing need for mental health services, which has become even more acute during the Covid-19 pandemic, good intentions are not being met with investment,” WHO Director General, Dr Tedros Adhanom Ghebreyesus, said in a statement.

“We must heed and act on this wake-up call and dramatically accelerate the scale-up of investment in mental health, because there is no health without mental health,” he added.

  • Related Posts

    Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

    The inspection revealed incomplete manufacturing records, poor hygiene, inadequate quality-control systems and the omission of ingredients specified in approved Ayurvedic formulations. The Maharashtra Food and Drug Administration (FDA) on Thursday…

    Amneal Pharma completes acquisition of Kashiv BioSciences

    Amneal Pharmaceuticals, Inc. announced the completion of its acquisition of Kashiv BioSciences, LLC, creating a fully integrated global biosimilars leader with end-to-end capabilities across research, development, manufacturing and commercialization. The…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

    Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

    Amneal Pharma completes acquisition of Kashiv BioSciences

    Amneal Pharma completes acquisition of Kashiv BioSciences

    Delhi High Court Directs Meesho to Remove Alleged Counterfeit Sun Pharma Sunscreen Listings

    Delhi High Court Directs Meesho to Remove Alleged Counterfeit Sun Pharma Sunscreen Listings

    IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

    IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

    AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

    AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

    NHS backs delayed‑release treatment for cystinosis

    NHS backs delayed‑release treatment for cystinosis